Vitestro raises EUR 12 million in Series A financing round to bring the world’s first autonomous blood drawing device to the European market
Vitestro, developer of an autonomous blood drawing device, announces the completion of a EUR 12 million Series A financing round. California-based Sonder Capital led the funding round alongside existing investors and new private investors with experience in the clinical laboratory and MedTech industry.